https://www.selleckchem.com/pr....oducts/azeliragon.ht
As CMV is a plausible driver of multiple comorbidities through persistent immune activation in treated HIV, future research is needed and planned to address its causal role as well as to test novel therapeutics in this setting. As CMV is a plausible driver of multiple comorbidities through persistent immune activation in treated HIV, future research is needed and planned to address its causal role as well as to test novel therapeutics in this setting. Older adults account for the majority of people with HIV (PWH) in high-income count
Like
Comment
Share
